Trial intelligence / Profile preview

Effect of allopurinol on left ventricular hypertrophy and endothelial dysfunction in normotensive chronic stable angina

2008-008479-32Phase 4Completed

Sponsor
University of Dundee
Start
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of allopurinol in angina pectoris, left ventricular hypertrophy (LVH) and endothelial dysfunction, sponsored by University of Dundee. Primary endpoint: Left ventricular hypertrophy regression on cardiac MRI. Started Jan 2009; status: completed.

02

Drugs

allopurinol
03

Conditions

angina pectorisleft ventricular hypertrophy (LVH)endothelial dysfunction

Beyond the preview

Go deeper on 2008-008479-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008479-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call